Drug Treatment of Allergic Conjunctivitis: A Review of the Evidence

Drugs

Volumn 43, Issue 2, 1992, Pages 154-176

  Ciprandi, Giorgio ^a,b   Buscaglia, Sandra ^a,b   Cerqueti, Piera M ^a,b   Canonica, Giorgio W ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ASTEMIZOLE; CELL ADHESION MOLECULE; CETIRIZINE; CHLORPHENIRAMINE; CINNARIZINE; CLARITIN D; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; DIPHENHYDRAMINE; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; KETOTIFEN; LEVOCABASTINE; LORATADINE; N ACETYLASPARTYLGLUTAMIC ACID; NAPHAZOLINE; NEDOCROMIL; OXATOMIDE; PHENYLPROPANOLAMINE; PIROXICAM; PSEUDOEPHEDRINE; SILVER NITRATE; TERFENADINE; TETRAHYDRAZOLINE; TETRIZOLINE; UNCLASSIFIED DRUG; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT; ZINC SULFATE;

ALLERGIC CONJUNCTIVITIS; CATARACT; CLINICAL FEATURE; CYTOLOGY; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG MIXTURE; DRUG THERAPY; HUMAN; IMMUNOTHERAPY; NAUSEA; OPHTHALMOLOGY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SEASONAL VARIATION; SEDATION; TOPICAL DRUG ADMINISTRATION; VERTIGO; XEROSTOMIA;

CONJUNCTIVITIS, ALLERGIC; HUMAN; SUPPORT, NON-U.S. GOV'T;

EID: 0026602178     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-199243020-00003     Document Type: Review

References (175)

1. Effects of topically applied ocular decongestant and antihistamines
2. Aspirin therapy in vernal conjunctivitis
3. The mechanisms of action of non steroidal antiinflammatory drugs
4. Review of the clinical activity and modes of action of sodium cromoglycate
5. Antigen-induced bronchial anaphylaxis in actively sensitized guinea pigs: effect of long-term treatment with sodium cromoglycate and aminophylline
6. Oxatomide: the prototype of a chemical series of compounds inhibiting both the release and the effects of allergic mediators
7. Evaluation of the CNS properties of SCH 29851, a potential nonsedating antihistamine
8. Cromoglycate de sodium en collyre dans les conjonctives allergiques: étude controlée multicentrique á double insu. Revue de la littérature
9. Therapy with cromolyn sodium
10. A double-blind study of astemizole and terfenadine in the treatment of perennial rhinitis
11. Inflammatory changes in conjunctival scraping after allergen provocation in humans
12. Late-phase ocular reaction induced by conjunctival allergen challenge: a dose response study in humans
13. L’acide N-acetyl aspartyl glutamique en collyre dans les conjonctivites de type allergique. Etude dinique comparative en double ensu
14. Antiallergic activity of loratadine and terfenadine assessed by nasal challenge
15. Clinical investigation of terfenadine, a nonsedating antihistamine
16. Perspective in platelet-activating factor
17. Evaluation of the antimuscarinic activity of atropine, terfenadine and mequitazine in healthy volunteers
18. Perennial rhinitis, treated with astemizole
19. Acrivastine: a review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders
20. Hay fever treatment with combined antihistamine and cyclooxygenase-inhibiting drugs
21. Double-blind placebo controlled comparison of cetirizine 2HC1 and terfenadine in atopic perennial rhinitis
22. Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis
23. Oral ketotifen versus disodium cromoglycate nasal spray for the prophylactic treatment of pollen-induced allergic manifestations
24. Astemizole (R43512) in the treatment of hay fever: an international double-blind study comparing a weekly treatment (10mg and 25mg) with a placebo
25. Cetrizine: a review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria
26. Antiallergic drugs and the immune response: interaction and possible clinical relevance
27. Drugs and the immune response: perspective in allergology
28. Eosinophils in disease: receptors and mediators
29. 2 -receptor blocking agents in seasonal rhinitis
30. Collirio di piroxicam nel trattamento di congiuntiviti allergiche pollinosiche
31. Treatment of vernal keratoconjunctivitis with topical cromolyn sodium
32. Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man
33. Protective effects of terfenadine on specific conjunctival provocation test
34. Levocabastine versus cromolyn sodium in the treatment of polleninduced conjunctivitis
35. Nonsteroidal treatment of pollinosic conjunctivitis: comparison of different pharmacologic protocols
36. Loratadine: a preliminary review of its pharmacodynamic properties and therapeutic efficacy
37. The effect of nedocromil sodium on nasal provocation with allergen
38. Disodium cromoglycate, FPL670 (Intal): a specific inhibitor of reaginic antibody/antigen mechanisms
39. Ketotifen: current views on its mechanism of action and their therapeutic implications
40. Dual inhibitory action of nedocromil sodium on antigen-induced inflammation
41. Prophylactic treatment of seasonal allergic rhinitis: a comparison of cetirizine (Zirtek) and terfenadine (Triludan)
42. Comparative trial of 2% sodium cromoglycate unit dose eye drops in seasonal allergic conjunctivitis
43. Levocabastine: a review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis
44. 1 -antagonists justify a reassessment of antihistamines in allergy treatment?
45. Oxatomide in the treatment of various allergic diseases
46. Inhibition of human eosinophils chemotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine
47. Safety and efficacy of loratadine (SCH-29851): a new non-sedating antihistamine in seasonal allergic rhinitis
48. Autacoids
49. Clinical trial with 2% sodium cromoglycate (Opticrom) in vernal keratoconjunctivitis
50. Inhibitory effect of cetirizine 2HC1 on eosinophil migration in vivo
51. Double-blind comparison of HEPP (IgE pentapeptide) 0.5% ophthalmic solution and sodium cromoglycate ophthalmic solution, USP 4% in patients having allergic conjunctivitis
52. Cetirizine in the treatment of seasonal rhinitis: a comparison with terfenadine
53. A clinical comparison of topical clobethasone butyrate and sodium cromoglycate in allergic conjunctivitis
54. Ocular allergy
55. Current concepts in ocular allergy
56. 1 antagonist
57. Antihistamines, drowsiness and psychomotor impairment: central nervous system effect of cetirizine
58. The late-phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease
59. Nedocromil sodium: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease
60. Ketotifen: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders
61. Sodium cromoglycate in ragweed-allergic conjunctivitis
62. Multicenter double-blind placebo-controlled trial of terfenadine suspension in the treatment of fall-allergic rhinitis in children
63. Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis
64. A double-blind study comparing sodium cromoglycate eye ointment with placebo in the treatment of chronic allergic conjunctivitis
65. Efficacy of nedocromil sodium 2% ophthalmic solution in the treatment of ragweed seasonal allergic conjunctivitis
66. 1 -antihistamines, terfenadine and astemizole for hay fever
67. Cromoglycate eye drops in hay-fever conjunctivitis: a new formulation appears to reduce stinging
68. Treatment of hay fever with loratadine, a new non-sedating antihistamine
69. Effects of oxatomide compared with chlorpheniramine in allergic rhinoconjunctivitis
70. Efficacy of continuous treatment with astemizole (Hismanal) and terfenadine (Seldane) in ragweed pollen-induced rhinoconjunctivitis
71. A double-blind trial of terfenadine and placebo in hay-fever using a substitution technique for non-responders
72. A comparison of cetirizine and chlorpheniramine vs placebo in the treatment of seasonal allergic rhinitis
73. Clinical comparison of IgE pentapeptide (HEPP) and cromolyn (opticrom) in allergic conjunctivitis. Abstract
74. Usefulness of immunotherapy in patients with summer hay fever uncontrolled by antiallergic drugs
75. Multicenter double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis
76. Terfenadine reduces skin and conjunctival reactivity in grass pollen allergic children
77. Antiallergic activity of loratadine, a non-sedating antihistamine
78. A double masked comparison of ocular decongestants as therapy for allergic conjunctivitis
79. 1 antagonist, astemizole
80. An action of disodium cromoglycate: inhibition of cyclic 3′,5′-AMP phosphodiesterase
81. A double-blind trial comparing astemizole and ketotifen in the suppression of hay fever symptoms
82. Double-blind group comparative study of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis
83. A multicenter double-blind group comparative study of 2% nedocromil sodium eye drops (Tilavist) with placebo eye drops in the treatment of seasonal allergic conjunctivitis
84. Late-phase allergic reactions
85. Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine)
86. Group comparative trial of 2% sodium cromoglycate (Opticrom) with placebo in the treatment of seasonal allergic conjunctivitis
87. Post-marketing surveillance of ketotifen (Zaditen): an interim report
88. Astemizole in the treatment of hay fever
89. Lack of tachyphylaxis during chronic administration of cetirizine 2HC1, an antagonist of peripheral H1 receptors
90. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection
91. A binding site on mast cells and basophils for the anti-allergic drug cromolyn
92. Terfenadine: an updated review of its pharmacological properties and therapeutic efficacy
93. Azelastine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential
94. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs
95. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin
96. Oxatomide in seasonal rhinoconjunctivitis
97. 2 antihistamine therapy in chronic urticaria
98. Epidemiology and natural history of asthma, allergic rhinitis and atopic dermatitis
99. The effects of nedocromil sodium on the activation of human eosinophils, neutrophils and histamine release from mast cells
100. Astemizole in the treatment of perennial non-allergic rhinitis
101. Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils
102. The effect of cetirizine on early allergic response
103. 2 antihistamines on histamine-induced bronchoconstriction and cutaneous wheal response in asthmatic patients
104. Treatment of ragweed allergic conjunctivitis with 2% cromolyn solution in unit doses
105. Newer antihistaminic agents
106. A comparative study of the efficacy of loratadine (L) and astemizole (A)
107. Clinical investigation of ketotifen in perennial allergic rhinitis: a double-blind comparative study of ketotifen and clemastine fumarate
108. Prophylactic effect of ketotifen on pollinosis
109. Efficacy of cetirizine in the treatment of seasonal allergic rhinoconjunctivitis
110. Antihistamine: pharmacology and clinical use
111. Comparison of one versus two daily doses of terfenadine: effects on skin tests
112. 1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test
113. 1 antagonist, in patients with allergic conjunctivitis
114. Cromoglicato disodico e corticoide topico nas conjunctivites atopicas cronicas e primaveris
115. Ketotifen in adult asthma
116. A Canadian multicenter study with Zaditen (ketotifen) in the treatment of bronchial asthma in children aged 5 to 17 years
117. 1 receptor antagonist in asthmatic airways
118. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season
119. Astemizole: a review of its pharmacodynamic properties and therapeutic efficacy
120. Oxatomide: a review of its pharmacodynamic properties and therapeutic efficacy
121. Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctival provocation tests
122. 2 antagonists in allergic and pseudoallergic diseases
123. Double-blind cross-over trial comparing beclomethasone dipropionate and terfenadine in perennial rhinitis
124. Sedative effects of antihistamines
125. Double-blind group comparative trial of sodium cromoglycate eye treatment and placebo in the treatment of allergic eye diseases
126. L’impiego per via topica di aspirina nelle congiuntiviti allergiche
127. Double blind comparative study of terfenadine vs ketotifen on perennial allergic rhinitis
128. Double-blind comparison of two effective treatments of perennial rhinoconjunctivitis
129. Effect of cetirizine in a conjunctival provocation test with allergens
130. Allergic conjunctivitis
131. 2 receptors in the human nose: rationale for topical use of combined antihistamine preparations
132. Cetirizine effects on objective measures of daytime sleepiness and performance
133. Effect of astemizole on human psychomotor performance
134. Aspirin and allergic disease: a review
135. Adverse reactions to cromolyn
136. Assessment of the duration of action of terfenadine on histamine induced weals
137. Overview of corticosteroids therapy
138. Lack of subsensitivity to terfenadine during long-term terfenadine treatment
139. Double-blind placebo-controlled study of loratadine, me-quitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis
140. Receptor effect of cetirizine
141. Terfenadine: a review of its pharmacodynamic properties and therapeutic efficacy
142. Ocular sodium cromoglycate: an overview of its therapeutic efficacy in allergic eye disease
143. Adhesion receptors of the immune system
144. Double blind group comparative trial of 2% nedocromil sodium eye drops in the treatment of seasonal allergy conjunctivitis
145. Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein
146. Effects of ketotifen and oxatomide on histamine secretion from mast cells
147. Antihistamines
148. Evolution of the late asthmatic reaction during immunotherapy and after stopping immunotherapy
149. Klinische Erprobung von N-acetyl-aspartyl-glutaminasäure Augentropfen bei subakuter und chronischer atopischer konjunktivitis
150. The evaluation of non steroidal antiinflammatory drugs and their mechanisms of action
151. In vitro effects of cetirizine and histamine on human neutrophil function
152. Immunotherapy for aeroallergen disease
153. Oxatomide in the treatment of chronic allergic rhinitis
154. Treatment of idiopathic chronic urticaria with oxatomide: a placebo-controlled study
155. Comparative trial of ketotifen and clemastine in childhood seasonal allergic rhinitis and asthma
156. Epidemiology of hay fever and perennial allergic rhinitis
157. Intercellular adhesion molecules-1 (ICAM-1) in the pathogenesis of asthma
158. Topical ocular administration of cromolyn sodium for treatment in seasonal ragweed conjunctivitis
159. Ketotifen in hay fever and allergic rhinitis
160. 1 -receptors in vivo determined by receptor binding techniques
161. Astemizole: a new long-acting antihistamine in the treatment of seasonal allergic rhinitis
162. Oxatomide: a new approach to the treatment of allergic rhinitis
163. Astemizole in maintenance therapy of hay-fever: a comparison with a long-acting formulation of pheniramine maleate
164. 14 C-cetirizine in humans
165. Effects of nedocromil sodium on the immediate response to allergen challenge in asthmatic patients
166. 1 antagonist, in a conjunctival provocation test with allergen